Treatment of the dimeric ruthenium halide complex [Ru(η-C6H6)Cl2]2 with 1,2,3-triphenylguanidine provided the tris-chelate [Ru{η2-(NPh)2CNHPh}3] with loss of the aromatic ligand and metal oxidation. This product may also be prepared by treatment of the previously reported [Ru(η-p-PriC6H4Me){η2-(NPh)2CNHPh}Cl] with bases (KOH, LiNiPr2, NEt3). Complexes containing chelating guanidinate ligands are also available by means of metathesis of the monolithiated ligands Li[C(NR)2NR2] with metal halide complexes, as exemplified by the synthesis of the square planar bis-chelate [Pt{η2-(NPh)2CNHPh}2] from [Pt(PhCN)2Cl2] and [Ti{η2-(NPh)2CN(Et)2}2Cl2] from [TiCl4(THF)2]. The characterisation of these complexes allows a comparison of the co-ordination properties of chelating guanidinates with early, middle and late transition metals.
No takes yet. Share an insight, caveat, or question.
Bailey et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: